Navigation Links
Arena Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference on April 4th
Date:3/27/2017

SAN DIEGO, March 27, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today announced that Amit Munshi, the Company's President and Chief Executive Officer, will present a corporate update at the 16th Annual Needham Healthcare Conference on Tuesday, April 4 at 3:40pm ET.  The conference will take place April 4-5, 2017 at the Westin New York Grand Central in New York, NY. 

A live audio webcast of the presentation will be available under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event.

About Arena Pharmaceuticals
Arena Pharmaceuticals is a biopharmaceutical company focused on developing novel, small molecule drugs with optimized receptor pharmacology designed to deliver broad clinical utility across multiple therapeutic areas. Our proprietary pipeline includes potentially first- or best-in-class programs for which we own global commercial rights.  Our three most advanced investigational clinical programs are ralinepag (APD811) in Phase 2 evaluation for pulmonary arterial hypertension (PAH), etrasimod (APD334) in Phase 2 evaluation for multiple autoimmune indications, and APD371 entering Phase 2 evaluation for the treatment of pain associated with Crohn's disease. In addition, Arena has collaborations with the following pharmaceutical companies: Eisai Co., Ltd. and Eisai Inc. (commercial stage), Axovant Sciences (Phase 2 candidate), and Boehringer Ingelheim International GmbH (preclinical candidate).

Forward-Looking Statements
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the upcoming presentation; and Arena's focus, the potential of its programs, and collaborations. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include those disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

Contact: Arena Pharmaceuticals, Inc.
Kevin R. Lind, Chief Financial Officer
klind@arenapharm.com
858.210.3636

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/arena-pharmaceuticals-to-present-at-the-16th-annual-needham-healthcare-conference-on-april-4th-300429469.html


'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Former Semi-Pro Arena Football Player Bridged to Heart Transplant with the SynCardia Total Artificial Heart
2. Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
3. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, August 1
4. Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
5. Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension
6. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7
9. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results
10. Arena Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
11. Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... ... July 17, 2019 , ... Princeton, New Jersey – ... today announced that it has been named a 2019 ‘Cool Vendor’ by Gartner, Inc. ... this year’s Cool Vendors research, we focused on two things. First, given the clear ...
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... Chlorophyll Water ... at the United Nations for International Yoga Day 2019. , International Day of ... June 21st. The day was declared unanimously by the United Nations General Assembly. , ...
(Date:7/17/2019)... ... 2019 , ... Burn Boot Camp, a nationwide health & ... Their Muscle” philanthropic event, and seventh year since the company’s inception, to support ... dystrophy, ALS and related neuromuscular diseases that severely weaken muscle strength and mobility. ...
Breaking Medicine Technology:
(Date:7/17/2019)... ... 17, 2019 , ... Becker's Healthcare is pleased to recognize ... men and women included on this list lead organizations regularly recognized for patient ... well as the construction of satellite clinics and strategic partnerships with local healthcare ...
(Date:7/17/2019)... MESQUITE, Texas (PRWEB) , ... July 17, 2019 , ... ... partnership with the Smiles for Everyone Foundation . Over 50 underserved patients were ... extractions , and more while celebrating the summer season. Individuals were referred to ...
(Date:7/17/2019)... ... July 16, 2019 , ... A medical home care program ... need is key to better care for seniors. While this may not sound surprising, ... Home (LAJH) through its Brandman Research Institute (BRI) uncovered several surprising outcomes based on ...
(Date:7/13/2019)... ... July 13, 2019 , ... ZALO , the leading luxury ... rechargeable vibrator and clitoral massager. To view the product and its accompanying video click ... most advanced, personal massagers to people around the world,” said Mara Epstein, director of ...
(Date:7/13/2019)... ... July 12, 2019 , ... China Focus ... Center , sponsored by Hangzhou Investment Promotion Bureau, Fox Rothschild LLP, MORE Health ... The conference attracted Fosun Pharmaceuticals, WuXi Biologics, Kelun Pharmaceutical, Harbin Pharmaceuticals, Fountain Medical, ...
Breaking Medicine News(10 mins):